Nicotine and sympathetic neurotransmission - PubMed (original) (raw)
Review
Nicotine and sympathetic neurotransmission
M Haass et al. Cardiovasc Drugs Ther. 1997 Jan.
Abstract
Nicotine increases heart rate, myocardial contractility, and blood pressure. These nicotine-induced cardiovascular effects are mainly due to stimulation of sympathetic neurotransmission, as nicotine stimulates catecholamine release by an activation of nicotine acetylcholine receptors localized on peripheral postganglionic sympathetic nerve endings and the adrenal medulla. The nicotinic acetylcholine receptor is a ligand-gated cation channel with a pentameric structure and a central pore with a cation gate, which is essential for ion selectivity and permeability. Binding of nicotine to its extracellular binding site leads to a conformational change of the central pore, which results in the influx of sodium and calcium ions. The resulting depolarization of the sympathetic nerve ending stimulates calcium influx through voltage-dependent N-type calcium channels, which triggers the nicotine-evoked exocytotic catecholamine release. In the isolated perfused guinea-pig heart, cardiac energy depletion sensitizes cardiac sympathetic nerves to the norepinephrine-releasing effect of nicotine, as indicated by a leftward shift of the concentration-response curve, a potentiation of maximum transmitter release, and a delay of the tachyphylaxis of nicotine-evoked catecholamine release. This sensitization was also shown to occur in the human heart under in vitro conditions. Through the intracardiac release of norepinephrine, nicotine induces a beta-adrenoceptor-mediated increase in heart rate and contractility, and an alpha-adrenoceptor-mediated increase in coronary vasomotor tone. The resulting simultaneous increase in oxygen demand and coronary resistance has a detrimental effect on the oxygen balance of the heart, especially in patients with coronary artery disease. Sensitization of the ischemic heart to the norepinephrine-releasing effect of nicotine may be a trigger for acute cardiovascular events in humans, such as acute myocardial infarction and/or life-threatening ventricular tachyarrhythmias.
Similar articles
- Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia.
Krüger C, Haunstetter A, Gerber S, Serf C, Kaufmann A, Kübler W, Haass M. Krüger C, et al. J Mol Cell Cardiol. 1995 Aug;27(8):1491-506. doi: 10.1016/s0022-2828(95)90194-9. J Mol Cell Cardiol. 1995. PMID: 8523413 - Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
Schömig A, Richardt G, Kurz T. Schömig A, et al. Herz. 1995 Jun;20(3):169-86. Herz. 1995. PMID: 7635399 Review. - Mechanism of nicotine-induced release of norepinephrine from adrenergic nerve endings: is generation and propagation of impulses necessary?
Jayasundar S, Vohra MM. Jayasundar S, et al. Arch Int Pharmacodyn Ther. 1978 Apr;232(2):202-10. Arch Int Pharmacodyn Ther. 1978. PMID: 209754 - Catecholamines in myocardial ischemia. Systemic and cardiac release.
Schömig A. Schömig A. Circulation. 1990 Sep;82(3 Suppl):II13-22. Circulation. 1990. PMID: 2203558 Review.
Cited by
- Sex difference in the associations among secondhand smoke with metabolic syndrome in non-smokers in a large Taiwanese population follow-up study.
Chiang TY, Pai CS, Geng JH, Wu PY, Huang JC, Chen SC, Chang JM. Chiang TY, et al. Int J Med Sci. 2024 May 28;21(8):1518-1528. doi: 10.7150/ijms.97306. eCollection 2024. Int J Med Sci. 2024. PMID: 38903920 Free PMC article. - Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations.
Mündel T. Mündel T. Sports Med. 2017 Dec;47(12):2497-2506. doi: 10.1007/s40279-017-0764-5. Sports Med. 2017. PMID: 28791650 Free PMC article. Review. - A prediction model for new-onset atrial fibrillation following coronary artery bypass graft surgery: A multicenter retrospective study.
Zhang RJ, Yu XY, Wang J, Lv J, Zheng Y, Yu MH, Zang YR, Shi JW, Wang JH, Wang L, Liu ZG. Zhang RJ, et al. Heliyon. 2023 Mar 21;9(3):e14656. doi: 10.1016/j.heliyon.2023.e14656. eCollection 2023 Mar. Heliyon. 2023. PMID: 37020944 Free PMC article. - Antioxidant supplementation prevents oxidation and inflammatory responses induced by sidestream cigarette smoke in old mice.
Zhang J, Jiang S, Watson RR. Zhang J, et al. Environ Health Perspect. 2001 Oct;109(10):1007-9. doi: 10.1289/ehp.011091007. Environ Health Perspect. 2001. PMID: 11675265 Free PMC article. - Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial.
Lyytinen G, Brynedal A, Anesäter E, Antoniewicz L, Blomberg A, Wallén H, Bosson JA, Hedman L, Mobarrez F, Tehrani S, Lundbäck M. Lyytinen G, et al. Cardiovasc Toxicol. 2023 Aug;23(7-8):255-264. doi: 10.1007/s12012-023-09802-9. Epub 2023 Aug 7. Cardiovasc Toxicol. 2023. PMID: 37548804 Free PMC article. Clinical Trial.